NASDAQ · Biotechnology

XBIT (XBIT) Stock

$2.26 -0.44% NASDAQ: XBIT Healthcare

Valuation

MetricValue
Price$2.26
Market Cap$68.90M
P/E Ratio-1.58
P/B Ratio0.51
P/S Ratio0.00
EPS (TTM)$-1.49
52-Week High$3.61
52-Week Low$2.09
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-25.93%
ROA-18.81%
ROCE-40.00%
Gross Margin0.00%
Operating Margin0.00%
Net Margin0.00%
Debt/Equity0.00
Current Ratio15.88

Annual Financials (USD)

Metric20212022202320242025
Revenue$18.0M$4.0M$0$0$0
Operating Profit$-25.0M$-34.0M$-38.0M$-42.0M$-56.0M
Net Profit$-17.0M$-33.0M$-25.0M$-39.0M$-46.0M
EPS$-0.58$-1.08$-0.81$-1.26$-1.49
Op Margin-136.4%-860.1%———

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$275.0M$246.0M$227.0M$199.0M$150.0M
Total Liabilities$6.0M$6.0M$8.0M$17.0M$10.0M
Cash$237.0M$157.0M$200.0M$173.0M$126.0M
Borrowings$0$0$0$10.0M$0

Latest News

XBiotech Launches Phase II Clinical Trial Evaluating Vilamakitug for the Treatment of Active Axial Spondyloarthritis GlobeNewswire · Jun 15, 2026 XBiotech: Q1 Earnings Snapshot Associated Press · May 14, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$69.0M$-15.0M$-19.0M$-31.0M$-40.0M
Investing Cash Flow$-7.0M$-64.0M$61.0M$-3.0M$-1.0M
Financing Cash Flow$8.0M$0$0$0$0
Net Cash Flow$0$-80.0M$43.0M$-27.0M$-47.0M
Free Cash Flow$66.0M$-15.0M$-19.0M$-32.0M$-40.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA0.94
FCF Yield-58.88%
Quick Ratio39.03
Interest Coverage—
Return 1Y-16.00%
Return 3Y-55.58%
Return 5Y-85.85%

Ownership

Insiders Held24.33%
Institutions Held6.81%
Institutions Float Held9.01%
Institutional HolderSharesReport Date
Blackrock Inc.293,1042026-03-31
Geode Capital Management, LLC231,0202026-03-31
Vanguard Capital Management LLC200,9712026-03-31
RBF Capital, LLC198,5012026-03-31
Morgan Stanley165,5542026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ACET $8.30 +1.22% -0.46 $77.59M 0.00%
ACRV $1.73 +2.37% -0.95 $74.05M 0.00%
ADAGAdagene Inc. $3.67 +1.66% -7.78 $138.17M 0.00%
CRVO $2.56 -3.76% -1.09 $23.70M 0.00%
FBIO $2.67 -3.61% 0.91 $88.69M 0.00%

About XBIT

XBIT is led by CEO Sushma Shivaswamy, employs 92 people, headquartered in US, publicly traded since 2015.

XBIT stock trades at $2.26 with a market capitalization of $68.90M. The stock is valued at a price-to-earnings (P/E) ratio of -1.58, price-to-book of 0.51, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $2.09 and $3.61, and currently trades 37.4% below its 52-week high.

On profitability, XBIT generates a return on equity (ROE) of -25.93%, return on capital employed of -40.00%, an operating margin of 0.00%, a net profit margin of 0.00%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides